ReviewLancet (London, England)2017
Essential medicines for universal health coverage.
Abstract readReview
In one paragraph
Review in Lancet (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 301 papers, 6 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
301citing papers in PubMed, 6 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
301 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Availability and affordability of essential medicines in African low- and middle-income countries: a systematic review and meta-analysis (2014-2025).BMC public health · 2026Pooled it
- Access to Essential Medicines in Low- and Middle-Income Countries: A Systematic Review of Barriers and Facilitators.International journal of public health · 2026Pooled it
- Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.Systematic reviews · 2022Pooled it
- The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.The Lancet. Global health · 2022Pooled it
- A systematic review of pooled procurement of medicines and vaccines: identifying elements of success.Globalization and health · 2022Pooled it
- Pharmaceutical policies: effects of regulating drug insurance schemes.The Cochrane database of systematic reviews · 2022Pooled it
- Economic Burden of Human Immunodeficiency Virus and Hypertension Care Among MOPHADHIV Trial Participants: Patient Costs and Determinants of Out-of-Pocket Expenditure in South Africa.International journal of environmental research and public health · 2025Trial
- Adherence at 2 years with distribution of essential medicines at no charge: The CLEAN Meds randomized clinical trial.PLoS medicine · 2021Trial
- Fortifying essential medicines supply chains in Sub-Saharan Africa - the curious cases of Kenya and Uganda.Global health action · 2026Review
- Medication access barriers and perceived health consequences in post-war Syria: a cross-sectional study in Homs.Global health action · 2026Article
- Territorial inequities in access to essential medicines for neglected tropical diseases in a decentralised European health system: a nationwide assessment in Spain.Infectious diseases of poverty · 2026Article
- Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026Article
- Balancing policy ambition and systems reality in expanding access to non-communicable diseases medicines: lessons from Ghana and Georgia.Health policy and planning · 2026Article
- Article
- Global health and economic impact of expanding the WHO essential medicines list for psoriasis: a health economic modelling study.EClinicalMedicine · 2026Article
- Article
- Interdisciplinary training on noncommunicable diseases and sustained change in primary health care in the context of health reform, COVID-19, and war in Ukraine: A repeated qualitative study, 2016-2022.BMC public health · 2026Article
- Clustering of countries based on national essential medicines lists: cross-sectional study.BMJ global health · 2026Article
- Article
- A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
241 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
22 authors.
Veronika J WirtzDepartment of Global Health/Center for Global Health and Development, Boston University School of Public Health, Boston, MA, USA. Electronic address: vwirtz@bu.edu.
Hans V HogerzeilGlobal Health Unit, Department of Health Sciences, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Andrew L GrayDivision of Pharmacology, Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa.
Maryam BigdeliWorld Health Organization, Geneva, Switzerland.
Cornelis P de JoncheereDepartment of Essential Medicines and Health Products, Geneva, Switzerland.
Margaret A EwenHealth Action International, Amsterdam, Netherlands.
Martha Gyansa-LutterodtMinistry of Health, Accra, Ghana.
Sun JingPeking Union Medical College School of Public Health, Beijing, China.
Vera L LuizaNational School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Regina M MbindyoWorld Health Organization, Country Office, Nairobi, Kenya.
Helene MöllerUnited Nations Children's Fund, Supply Division, Copenhagen, Denmark.
Corrina MoucheraudUCLA Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Bernard PécoulDrugs for Neglected Diseases initiative, Geneva, Switzerland.
Lembit RägoRegulation of Medicines and other Health Technologies, Geneva, Switzerland.
Arash RashidianDepartment of Information, Evidence and Research, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Dennis Ross-DegnanResearch, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; Harvard Medical School, Boston, MA, USA; Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Peter N StephensIMS Health, London, UK.
Yot TeerawattananonHealth Intervention and Technology Assessment Program (HITAP), Thai Ministry of Public Health Nonthaburi, Thailand.
Ellen F M 't HoenGlobal Health Unit, Department of Health Sciences, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Anita K WagnerResearch, Eastern Mediterranean Region, World Health Organization, Cairo, Egypt; Harvard Medical School, Boston, MA, USA.
Prashant YadavWilliam Davidson Institute at the University of Michigan, Ann Arbor, MI, USA.
Michael R ReichHarvard T H Chan School of Public Health, Boston, MA, USA.
Funding
Wellcome TrustWorld Health Organization 001
Abstract
PubMed holds no abstract for this paper.
Indexed as
Conservation of Natural ResourcesDeveloping CountriesDrug CostsHealth ExpendituresUniversal Health InsuranceDrugs, EssentialHumansWorld Health OrganizationDrugs, Essential
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.